Bormioli Pharma completes acquisition

Italian glass manufacturer Bormioli Pharma has completed the acquisition of GCL Pharma.

GCL Pharma is an Italian company that specialises in pharma closures.

Bormioli Pharma said: “It’s a new and relevant step in the right direction along our growth path, allowing us to serve the global pharma industry with more energy and renewed resources.”

The pharmaceutical glassmaker issued a binding offer of €8.9 million last month for GCL, which is a subsidiary of the Guala Closures Group.

GCL specialises in the production of plastic, rubber and aluminium closures for pharmaceutical applications.

In 2019 GCL Pharma recorded a turnover of approximately €8 million. The company’s main premises and production plant are located in Vasto, Chieti, Italy.

07.05.2020, Bormioli Pharma

Il materiale informativo del sito è registrato ed appartiene all´azienda o ai terzi che lo hanno fornitoe tutti i diritti sono riservati. Qualsiasi utente che accede a tale materiale può farlo solo ad uso personale e ne è anche responsabile. Ridistribuzione o altro uso commerciale di tale materiale è espressamente proibito. Nel caso in cui il materiale sia stato ceduto da terzi, l´utente concorda di rispettare questi termini di utilizzo specificati. Glass Global non garantisce la veridicità o l´esattezza del contenuto di alcuna informazione o di siti web esterni menzionati nelle stesse.

Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.